Recently the Department of Health and Human Services, led by their inspector general have discovered that drug manufactures are neglecting to submit quarterly and monthly updates on pricing data, that greatly affect the discounts Medicaid patients receive. Under Federal law since 1990 the government has the right to fine any companies that fail to report their costs and data $10,000 a day until the numbers have been collected. This practice has been unenforced up to this point costing the government and Medicaid a substantial amount of money in overpaid prescription medicine. The new enforcement of this law will save the federal government 35 billion dollars over the next 10 years, not only through discounts but the use of generic prescriptions, in favor of the brand-name. The continued enforcement and responsibility of the drug companies will help to lower the ever growing costs of health care in the U.S.
http://www.nytimes.com/2010/10/03/us/03drug.html?_r=1&ref=us
Ben Rains
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment